Literature DB >> 32401551

Do the current guidelines for asthma pharmacotherapy encourage over-treatment?

Diego Bagnasco1, Luisa Brussino2, Cristiano Caruso3, Giovanni Paoletti4,5, Enrico Heffler4,5, Giuseppe Guida6, Elisa Calzolari1, Stefania Nicola2, Laura De Ferrari1, Giovanni Passalacqua1, Giorgio Walter Canonica4,5.   

Abstract

Entities:  

Keywords:  Asthma; GINA; ICS/formoterol; allergen immunotherapy; inhaled corticosteroids; mild asthma; steroids side effects

Year:  2020        PMID： 32401551     DOI： 10.1080/14656566.2020.1759551

Source DB:  PubMed          Journal:  Expert Opin Pharmacother        ISSN： 1465-6566            Impact factor:   3.889


× No keyword cloud information.
  3 in total

1.  Biologics in Severe Eosinophilic Asthma: Three-Year Follow-Up in a SANI Single Center.

Authors:  Paolo Solidoro; Stefania Nicola; Irene Ridolfi; Giorgio Walter Canonica; Francesco Blasi; Pierluigi Paggiaro; Enrico Heffler; Diego Bagnasco; Filippo Patrucco; Fulvia Ribolla; Caterina Bucca; Giovanni Rolla; Carlo Albera; Luisa Brussino
Journal:  Biomedicines       Date:  2022-01-18

2.  COPD, but Not Asthma, Is Associated with Worse Outcomes in COVID-19: Real-Life Data from Four Main Centers in Northwest Italy.

Authors:  Stefania Nicola; Richard Borrelli; Irene Ridolfi; Virginia Bernardi; Paolo Borrelli; Giuseppe Guida; Andrea Antonelli; Carlo Albera; Stefania Marengo; Antonio Briozzo; Claudio Norbiato; Agata Valentina Frazzetto; Marina Saad; Luca Lo Sardo; Beatrice Bacco; Silvia Gallo Cassarino; Stefano Della Mura; Diego Bagnasco; Caterina Bucca; Giovanni Rolla; Paolo Solidoro; Luisa Brussino
Journal:  J Pers Med       Date:  2022-07-20

Review 3.  Amlexanox: A Novel Therapeutic for Atopic, Metabolic, and Inflammatory Disease.

Authors:  Amrita Dosanjh; Cindy Y Won
Journal:  Yale J Biol Med       Date:  2020-12-29
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.